Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000477563 | SCV000560280 | likely benign | Hereditary breast ovarian cancer syndrome | 2023-12-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000561963 | SCV000661002 | likely benign | Hereditary cancer-predisposing syndrome | 2016-02-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001707704 | SCV000727031 | likely benign | not provided | 2019-11-12 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000561963 | SCV000910216 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-14 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003492067 | SCV004240194 | likely benign | Breast and/or ovarian cancer | 2022-08-15 | criteria provided, single submitter | clinical testing |